2010
DOI: 10.1590/s0365-05962010000500005
|View full text |Cite
|
Sign up to set email alerts
|

Importância da variação do PASI realizado por diversos observadores

Abstract: BACKGROUND: Developed in 1978, the PASI (Psoriasis Area and Severity Index) is a method to rate psoriasis severity. Since then, it has been criticized for being extremely long, complex and for yielding significantly divergent interpretations. OBJECTIVE: To determine the PASI inter-rater reliability among three independent evaluators examining the same patients. METHODS: Cross-sectional study conducted in 2007 at a psoriasis treatment center, where 20 patients were selected. The patients were evaluated by three… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0
2

Year Published

2012
2012
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(18 citation statements)
references
References 7 publications
1
13
0
2
Order By: Relevance
“…Thus, the PASI can be inaccurate inter-individually and even show time-to-time variability in a single rater 3 5 . Therefore, expert training is required to minimize inter-rater and intra-rater variability in PASI assessment 6 . However, in actuality, most clinics do not provide residents with PASI assessment training.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the PASI can be inaccurate inter-individually and even show time-to-time variability in a single rater 3 5 . Therefore, expert training is required to minimize inter-rater and intra-rater variability in PASI assessment 6 . However, in actuality, most clinics do not provide residents with PASI assessment training.…”
Section: Introductionmentioning
confidence: 99%
“…Coefficients ≥0.7 represent good agreement and coefficients <0.5 represent mediocre or poor agreement. [24,25] The ICC was ≤0.45 in more than half the observations in our study.…”
Section: Discussionmentioning
confidence: 44%
“…The inclusion criteria were as follows: patients did not receive systemic or local treatment with psoriasis drugs (including corticosteroids, immuno-suppressants and psoralen ultraviolet-A (PUVA) therapy) two months before enrollment; patients stopped using local glucocorticoids and other drugs for topical use for at least four weeks; patients had no systemic application of anti-psoriasis drugs, including oral corticosteroids, immunosuppressive agents, etc., for more than six weeks; and patients did not have accompanying heart, liver or kidney dysfunction or other systemic disorders. The severity of the disease in patients with psoriasis was determined in accordance with the psoriasis area and severity index (PASI), and the PASI scores of patients with psoriasis were recorded [25] The PASI scores of the patients with psoriasis were 8.3-46.9 (averaged 28.5).…”
Section: Methodsmentioning
confidence: 99%